EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,095 | +148.9% | 50,117 | +117.7% | 0.09% | +113.6% |
| Q2 2023 | $440 | +125.6% | 23,026 | +89.6% | 0.04% | +83.3% |
| Q4 2022 | $195 | -100.0% | 12,145 | -89.3% | 0.02% | -89.8% |
| Q3 2022 | $1,776,000 | +49.7% | 113,271 | +98.8% | 0.24% | +32.6% |
| Q2 2022 | $1,186,000 | +444.0% | 56,974 | +491.2% | 0.18% | +513.8% |
| Q1 2022 | $218,000 | -34.3% | 9,637 | -34.5% | 0.03% | -47.3% |
| Q1 2021 | $332,000 | +28.7% | 14,714 | -1.8% | 0.06% | -15.4% |
| Q1 2020 | $258,000 | +5.3% | 14,989 | +7.8% | 0.06% | +124.1% |
| Q4 2019 | $245,000 | -30.8% | 13,900 | -30.5% | 0.03% | -39.6% |
| Q3 2019 | $354,000 | +24.2% | 20,014 | +50.2% | 0.05% | +50.0% |
| Q2 2019 | $285,000 | -1.0% | 13,322 | +10.2% | 0.03% | +10.3% |
| Q1 2019 | $288,000 | -26.9% | 12,084 | -39.6% | 0.03% | -35.6% |
| Q4 2018 | $394,000 | -26.4% | 20,010 | -19.5% | 0.04% | +66.7% |
| Q2 2018 | $535,000 | -83.7% | 24,869 | -83.2% | 0.03% | -84.5% |
| Q1 2018 | $3,286,000 | -24.7% | 148,369 | +3.3% | 0.17% | -34.6% |
| Q4 2017 | $4,365,000 | +226.0% | 143,594 | +159.9% | 0.27% | +192.3% |
| Q3 2017 | $1,339,000 | +16.2% | 55,251 | +18.1% | 0.09% | +21.3% |
| Q2 2017 | $1,152,000 | -7.8% | 46,781 | -18.8% | 0.08% | +11.9% |
| Q1 2017 | $1,249,000 | +117.2% | 57,626 | +49.3% | 0.07% | +97.1% |
| Q4 2016 | $575,000 | +20.5% | 38,589 | +3.4% | 0.03% | +30.8% |
| Q3 2016 | $477,000 | +307.7% | 37,318 | +149.1% | 0.03% | +333.3% |
| Q2 2016 | $117,000 | +80.0% | 14,982 | +30.3% | 0.01% | +100.0% |
| Q4 2015 | $65,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |